Track FDA investigations, drug approvals, disease outbreaks, and public health policy changes over time. Pingmer follows the regulatory and medical timeline and pings you when something shifts — a drug is approved, an outbreak spreads, or guidelines change.
As of May 8, 2026, South Carolina leads the nation with 669 reported measles cases, contributing to a nationwide total of 1,842 confirmed cases in 2026. Data indicates that 92% of individuals who contracted measles in 2026 were unvaccinated or had an unknown vaccination status.
The Countryside Alliance has declared the government's proposed consultation on aligning shotgun and firearms licensing a "existential and generational threat to shooting." This statement comes amid ongoing reviews and debates surrounding UK firearms licensing laws.
Видео от 15 марта 2026 года детализирует события в Прокопьевском психоневрологическом интернате, исследуя хронологию вспышки гриппа А, причины массовых смертей и реакцию властей. Расследование указало на преднамеренное бездействие как фактор, способствовавший трагедии.
A phase two clinical trial is testing ketamine for Long COVID fatigue and cognitive function, with further research planned for Multiple Sclerosis (MS) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Evidence suggests ketamine may offer symptom relief for ME/CFS by addressing central nervous system dysfunction and neuroinflammation.
The CDC and FDA have declared the multistate outbreak of extensively drug-resistant Salmonella linked to Rosabella brand moringa powder capsules as over. The investigation confirmed the capsules were contaminated and caused illness, with consumers still advised not to consume or sell recalled products due to their long shelf life.
Researchers announce plans to expand the clinical trials to include children aged 2-7 who suffer from congenital anodontia, following the successful completion of the initial adult safety trials.
A submission for approval of zoliflodacin in South Africa is planned for early 2026.
Actor Quinton Aaron revealed in an April 20, 2026, interview that he aims to walk again sooner than projected following his January spinal stroke. During his recovery, he discovered his wife's existing legal marriage prevented her from making medical decisions for him. Aaron was hospitalized in January 2026 for a severe blood infection and spinal cyst, later diagnosed as a spinal stroke.
The UK's PATHWAYS clinical trial for puberty blockers was paused on February 21, 2026, following concerns from the MHRA regarding participant wellbeing and a recommended minimum age of 14 due to potential long-term biological harms. As of March 1, 2026, Professor Jacob George, chief medical and scientific officer at the MHRA, was removed from further involvement in the trial due to accusations of bias, despite his social media posts predating his appointment. Discussions are ongoing between the MHRA and King's College London, the trial sponsor, with recruitment halted until issues are resolved. This pause follows legal challenges from campaigners and NHS England's 2024 decision to restrict puberty blockers to research settings.
Mayo Clinic researchers have developed an AI model, REDMOD, capable of detecting subtle tissue changes indicative of pancreatic cancer on routine CT scans, potentially years before clinical diagnosis. The AI model identified 73% of prediagnostic cancers a median of 16 months earlier than specialists and nearly three times as many early cancers when examining scans from over two years prior to diagnosis.
Tim Andrews, a recipient of a gene-edited pig kidney transplant in January 2025, has died after seven months. His transplanted kidney had been functioning, filtering waste and producing urine, before his death. This case is part of ongoing research into xenotransplantation to address organ shortages.
Three new cases of meningitis B have been confirmed in Weymouth, Dorset, presenting a different sub-strain from the earlier outbreak in Kent. Health officials are offering vaccinations and antibiotics as a precaution in Dorset, though these cases are not linked to the Kent outbreak.
Drs. Kiran Musunuru and Rebecca Ahrens-Nicklas were recognized among TIME's 100 Most Influential People of 2026 for their pioneering work on personalized CRISPR gene therapy for CPS1 deficiency. This therapy, developed for infant KJ Muldoon, represents a historic milestone in treating rare genetic diseases.
The drug daraxonrasib, targeting KRAS mutations, has received the U.S. Food and Drug Administration's fastest track for approval. This drug, which has shown promise in clinical trials when combined with chemotherapy, is part of a new generation of KRAS inhibitors designed to combat treatment resistance.
The Fertility Center of Orlando will cease operations following multiple lawsuits alleging an embryo mix-up. Attorneys are working to identify the child's genetic parents and notify other potentially affected patients. A separate lawsuit involves a surrogate claiming the clinic failed to identify a genetic issue.
Nurses in New York City have returned to work following the conclusion of a strike, as noted in the Federal Reserve Bank of New York's April 2026 Beige Book.
The World Health Organization has assessed the Nipah virus outbreak in West Bengal, India, classifying subnational risk as moderate and national, regional, and global risks as low. Several countries in the region, including Thailand, Nepal, Cambodia, Indonesia, and Malaysia, have initiated precautionary measures such as public information campaigns and passenger screenings.
As of April 4, 2026, sixteen pediatric flu deaths have been reported for the season in New York City. For the week ending April 4, 2026, influenza B accounted for 89% of positive flu cases in New York City, with influenza A following.
Consumer Reports released a follow-up investigation in March 2026, testing 49 additional infant formulas for heavy metals and other contaminants. Some formulas showed potentially concerning levels of inorganic arsenic, lead, and PFAS.
The first human participants, including Jennifer Davis, began receiving the experimental vaccine in the fall of 2021. [4]